Zynerba Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q4 2014 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Zynerba Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2014 to Q2 2023.
  • Zynerba Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2023 was 53.9M shares, a 22.8% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 53.9M +10M +22.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 53.5M +10.2M +23.5% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 47.9M +6.68M +16.2% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 47.1M +5.78M +14% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 43.9M +2.68M +6.51% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 43.3M +2.07M +5.02% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 41.2M +11.2M +37.5% Dec 31, 2021 10-K 2023-03-28
Q3 2021 41.3M +11.8M +40.2% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 41.3M +12M +41% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 41.3M +17.7M +75% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 30M +6.76M +29.1% Dec 31, 2020 10-K 2022-03-01
Q3 2020 29.4M +6.25M +26.9% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 29.3M +6.06M +26.1% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 23.6M +2.5M +11.9% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 23.2M +5.58M +31.7% Dec 31, 2019 10-K 2021-03-10
Q3 2019 23.2M +5.57M +31.6% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 23.2M +9.64M +71.1% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 21.1M +7.51M +55.4% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 17.6M +4.07M +30.1% Dec 31, 2018 10-K 2020-03-10
Q3 2018 17.6M +4.37M +32.9% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 13.6M +304K +2.29% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 13.6M +347K +2.62% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 13.6M +3.56M +35.6% Dec 31, 2017 10-K 2019-03-11
Q3 2017 13.3M +3.63M +37.7% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 13.3M +4.06M +44.1% Jun 30, 2017 10-Q 2017-08-01
Q1 2017 13.2M +4.01M +43.6% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 9.99M +795K +8.64% Dec 31, 2016 10-K 2018-03-12
Q3 2016 9.63M +428K +4.66% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 9.2M +7.17M +353% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 9.2M Mar 31, 2016 10-Q 2016-05-12
Q4 2015 9.2M +7.17M +353% Dec 31, 2015 10-K 2017-03-27
Q3 2015 9.2M Sep 30, 2015 10-Q 2015-11-12
Q2 2015 2.03M Jun 30, 2015 10-Q 2015-08-27
Q4 2014 2.03M Dec 31, 2014 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.